Revolutionary hemostatic gel for veterinary surgeons available in U.K. and across Europe through Veterinary Instrumentation and distribution partnersNEW YORK, May 20, 2024 /PRNewswire/ -- Cresilon Inc. ('Cresilon'), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons in the U.K.

2024年5月20日，纽约/PRNewswire/--Cresilon Inc.（“Cresilon”），一家总部位于布鲁克林的专注于止血医疗器械技术的生物技术公司，今天宣布，它已经签订了一项分销协议，将其革命性的止血凝胶VETIGEL®直接出售给英国的兽医。

and throughout Europe through Veterinary Instrumentation (Vi), a leading supplier of professional products to support veterinarians in maintaining animal welfare during surgery..

并通过兽医仪器（Vi）在整个欧洲提供专业产品的领先供应商，以支持兽医在手术期间维持动物福利。。

Based in the U.K., Vi is part of the Covetrus animal health family of worldwide businesses. Cresilon's VETIGEL, a plant-based hemostatic gel that instantly stops and controls bleeding, is available online for U.K. veterinary surgeons through Vi's extensive portfolio of surgical and orthopedic instrumentation, joint surgery, and fracture fixation products..

Vi总部位于英国，是Covetrus animal health全球业务家族的一部分。Cresilon的VETIGEL是一种基于植物的止血凝胶，可立即停止和控制出血，可通过Vi广泛的外科和骨科仪器，关节手术和骨折固定产品组合在线提供给英国兽医。。

In addition to the U.K., VETIGEL will be marketed and distributed to veterinary surgeons throughout Europe and many other countries through Vi's extensive global distribution network. Cresilon's Scientific Services Veterinarian and Fellow of the Royal College of Veterinary Surgeons (FRCVS), Dr. Neil Smith, will be providing online training on VETIGEL to all Vi distribution partners in June. .

除英国外，VETIGEL还将通过Vi广泛的全球分销网络向欧洲和许多其他国家的兽医销售和分销。Cresilon的科学服务兽医兼皇家兽医学院（FRCVS）研究员Neil Smith博士将于6月向所有Vi分销合作伙伴提供VETIGEL的在线培训。。

'Our partnership with Veterinary Instrumentation will help us provide more veterinary surgeons with a revolutionary hemostatic gel that significantly improves the standard of care for pets and animals,' said Matt Lewis, Vice President of Sales at Cresilon. 'VETIGEL has been used by thousands of veterinarians thus far and helps veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes.'Since the product's debut in 2021, veterinary surgeons across North America, Europe, and Asia have increasingly used VETIGEL as the fastest and most effective hemostatic agent when treating animals for traumatic wounds and routine and complex surgical procedures, including dental extractions, liver biopsies, tumor and mass removals, cleft palate repairs, and amputations.

Cresilon销售副总裁马特·刘易斯（MattLewis）说：“我们与兽医仪器的合作将帮助我们为更多的兽医提供革命性的止血凝胶，大大提高宠物和动物的护理标准。”迄今为止，VETIGEL已被数千名兽医使用，帮助兽医诊所和动物医院节省时间，降低运营成本，改善患者预后。”自2021年该产品首次亮相以来，北美，欧洲和亚洲的兽医越来越多地使用维替格作为治疗动物创伤性伤口和常规复杂外科手术（包括拔牙，肝活检，肿瘤和肿块切除，腭裂修复和截肢）时最快和最有效的止血剂。

To date, the plant-based hemostatic gel for veterinary surgeons has been used in more than 50,000 surgical procedures worldwide.VETIGEL offers veterinary surgeons a safe and efficient way to control animal bleeding across multiple types of bleeds and a wide range of surgical procedures. The veterinary hemostatic agent is made of two plant-based polysaccharides that form an instant mechanical barrier to stop bleeding on contact.

迄今为止，用于兽医的植物止血凝胶已在全球50000多种外科手术中使用。VETIGEL为兽医提供了一种安全有效的方法来控制多种类型的出血和广泛的外科手术中的动物出血。兽医止血剂由两种基于植物的多糖制成，它们形成即时的机械屏障，可在接触时止血。

Once the bleeding is controlled, VETIGEL can be easily removed without disturbing the underlying clot or left in the body to resorb.The plant-based hemostatic gel is supplied in a pre-filled syringe, is easy-to-use, and requires no preparation or special storage conditions. For more information about VETIGEL, visit www.vetigel.com.About CresilonCresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel technology.

一旦出血得到控制，VETIGEL可以很容易地去除，而不会干扰潜在的凝块或留在体内再吸收。基于植物的止血凝胶在预先填充的注射器中提供，易于使用，不需要制备或特殊的储存条件。有关VETIGEL的更多信息，请访问www.VETIGEL.com.about CresilonCresilon®是一家总部位于布鲁克林的生物技术公司，利用该公司专有的水凝胶技术开发、制造和销售止血医疗设备。